NPI registry status
Active
2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1497054605 M.D.
Verify on CMS → David Gay, M.D.
Ophthalmic Plastic and Reconstructive Surgery Physician in Dripping Springs, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 303 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
350
Medicare Part D claims · 133 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 642
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$20.4K
38 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
David Gay, M.D. filed 350 Medicare Part D claims in 2024 as an Ophthalmic Plastic and Reconstructive Surgery Physician in Dripping Springs, Texas, prescribing 95% generic.
- 350
- Part D claims, 2024
- 95%
- generic prescribing
- $20.4K
- industry payments (Sunshine Act)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about David Gay, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1497054605), first enumerated 03/28/2011.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 350 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$20.4K in reported industry payments (38 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not David Gay, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1497054605 · Ophthalmic Plastic and Reconstructive Surgery Physician
NPI-10 · ENUM-MID · TAX-TRACE · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1497054605
- ENUM-MID 2011
- TAX-TRACE 303
- RX-LIGHT 350
- BOOK-THIN 29 in Texas
- PHOTO-ENUM Michael Chappell, MD · 2011
David Gay, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
350 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
David Gay, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Gay, M.D.?
Quality data not reportedPrimary specialty
Ophthalmic Plastic and Reconstructive Surgery Physician
Medicare Part D claims
350 45% vs specialty avg
Specialty distribution in Texas
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmic Plastic and Reconstructive Surgery Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1497054605 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/28/2011 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Gay, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$20.4K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to David Gay, M.D.. To verify David Gay, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
David Gay, M.D. - brand share 5.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average
5% brand-name claims vs 95% generic, on 350 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
350
Total Claims
$4K
Total Drug Cost
133
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 354.367
- Total Day Supply
- 4,648
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $1K
- Generic Drug Cost
- $3K
- Opioid Claims
- 93 (26.6% rate)
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.22
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What David Gay, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
120 claims
- Tramadol Hcl
Tramadol Hcl
87 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
63 claims
- Prednisolone Acetate 13
Prednisolone Acetate
13 claims
- Azithromycin 11
Azithromycin
11 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 120 |
| Tramadol Hcl | 87 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 63 |
| Prednisolone Acetate | 13 |
| Azithromycin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Ophthalmic Plastic and Reconstructive Surgery Physician in TX →
All providers in Texas →
Compare specialties →
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How David Gay, M.D. fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
303
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
44
States with Ophthalmic Plastic and Reconstructive Surgery Physician
642
Avg Claims per Provider
David Gay, M.D.'s 350 claims are below the specialty average of 642.
Nationwide Ophthalmic Plastic and Reconstructive Surgery Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gay, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Gay.
One of 29 Ophthalmic Plastic and Reconstructive Surgery Physician providers enrolled in Texas, 5 are shown here.
Frequently Asked Questions
What is David Gay, M.D.'s specialty? ▼
David Gay, M.D. specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Dripping Springs, Texas. Credentials: M.D..
How much does David Gay, M.D. prescribe under Medicare Part D? ▼
In 2024, David Gay, M.D. wrote 350 Medicare Part D claims totaling $4K in drug costs for 133 beneficiaries.
Where is David Gay, M.D. located? ▼
David Gay, M.D. is located at 13830 SAWYER RANCH RD STE 201, Dripping Springs, TX, 78620. Phone: (512) 607-6884.
What is David Gay, M.D.'s NPI number? ▼
David Gay, M.D.'s National Provider Identifier (NPI) is 1497054605, issued on 03/28/2011.
Does David Gay, M.D. prescribe more brand-name or generic drugs? ▼
David Gay, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $1K in brand drug costs.
Does David Gay, M.D. prescribe opioids? ▼
Yes, David Gay, M.D. had 93 opioid claims in 2024 with an opioid prescribing rate of 26.6%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 303 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 44 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 642 Medicare Part D claims per year.
What drugs does David Gay, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, David Gay, M.D.'s most frequently prescribed drugs include Erythromycin, Tramadol Hcl, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Gay, M.D. accept Medicare? ▼
David Gay, M.D. appears in CMS Medicare data with 350 Part D claims and 133 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Gay, M.D.'s credentials? ▼
David Gay, M.D.'s NPI is 1497054605 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.